Nomura Micro Science (6254) Q1 2027 earnings summary

Executive summary

• Orders received in Q1 FY2026 surged 783.4% year-over-year to ¥38,891 million, driven by large-scale water treatment equipment projects in Japan and East Asia.

• Q1 FY2026 sales reached ¥15,198 million, showing growth compared to Q1 FY2025, but some sources report a decline to ¥9,202 million due to project completions in the US and Japan.

• Gross profit margin improved to 23.1% in Q1 FY2026 from 22.4% in Q1 FY2025.

• Operating income for Q1 FY2026 was ¥1,682 million, with an operating margin of 11.2%, though another source notes a drop to ¥628 million.

• Comprehensive income rose sharply to ¥788 million, up 498.5% year-over-year, mainly due to foreign currency translation gains.

Financial highlights

• Net sales for Q1 FY2026 were reported as ¥15,198 million (up from ¥12,403 million in Q1 FY2025) and also as ¥9,202 million (down 25.8% YoY) due to project completions.

• Operating income for Q1 FY2026 was ¥1,682 million (margin 11.2%) or ¥628 million (down 54.4% YoY).

• Profit attributable to owners of parent in Q1 FY2026 was ¥952 million or ¥239 million (down 48.4% YoY).

• Order backlog at the end of Q1 FY2026 was ¥38,891 million, up 88.9% year-over-year.

• Basic earnings per share: ¥6.25 (down from ¥12.27 YoY).

Outlook and guidance

• Full-year FY2026 sales forecast is ¥97,000 million.

• Operating income forecast for FY2026 is ¥16,000 million.

• Orders received forecast for FY2026 is ¥164,780 million.

• Interim dividend forecast raised to ¥30.00 per share, full-year dividend forecast at ¥85.00 per share.

• No changes to the previously announced earnings forecasts for FY ending March 31, 2027.